Hypothesis: Targeted Ikkβ deletion upregulates MIF signaling responsiveness and MHC class II expression in mouse hepatocytes
Katherine S Koch, Hyam L LeffertHepatocyte Growth Control and Stem Cell Laboratory, Department of Pharmacology, School of Medicine, University of California, San Diego, CA, USAAbstract: Macrophage migration inhibitory factor (MIF) is causally related to the pathogenesis of chronic liver disease but...
Main Authors: | Katherine S Koch, Hyam L Leffert |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-03-01
|
Series: | Hepatic Medicine : Evidence and Research |
Online Access: | http://www.dovepress.com/hypothesis-targeted-ikkbeta-deletion-upregulates-mif-signaling-respons-a4115 |
Similar Items
-
Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer’s disease
by: Si Zhang, et al.
Published: (2019-06-01) -
Upregulated mTOR Signaling through IKK-beta Increases Cell Proliferation and VEGF Production in Hepatocellular Carcinoma and Esophageal Adenocarcinoma
by: Chia-JuiYen, et al.
Published: (2012) -
Hepatocyte IKK2 protects Mdr2-/- mice from chronic liver failure.
by: Hanno Ehlken, et al.
Published: (2011-01-01) -
Hepatocyte-Specific Deletion of Mouse Lamin A/C Leads to Male-Selective SteatohepatitisSummary
by: Raymond Kwan, et al.
Published: (2017-11-01) -
Gender difference in NASH susceptibility: Roles of hepatocyte Ikkβ and Sult1e1.
by: Noriko Matsushita, et al.
Published: (2017-01-01)